Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

A near telomere-to-telomere genome assembly of the tobacco root rot pathogen Fusarium oxysporum.

Created on 30 Jun 2026

Authors

Rui Wang, Xiaotong Gai, Wei Guo

Published in

Scientific data. Jun 30, 2026. Epub Jun 30, 2026.

Abstract

Fusarium oxysporum is a critically important pathogen with significant impacts on both agriculture and public health. In agriculture, it causes vascular wilt and root rot in numerous crops, resulting in substantial economic losses. This threat is compounded by the fungus's high genetic diversity, adaptability, and persistence in the environment, which make its control particularly challenging. In this study, we report a near telomere-to-telomere (T2T) genome assembly of Fusarium oxysporum strain Fo-129, a highly virulent strain causing tobacco root rot in China. It achieved a BUSCO completeness of 96.9%. The genome contains 24 identifiable telomeres, 9.40% repeat sequences, 15,102 protein-coding genes, 370 ncRNAs, and 538 candidate effector protein-coding genes. Additionally, 52 secondary metabolite gene clusters and 714 carbohydrate-active enzymes were also identified. This near T2T genome assembly of a pathogenic F. oxysporum strain provides a crucial genomic resource for advancing research into fungal pathogenicity, host adaptation, accessory chromosome evolution, and the molecular basis of host-pathogen interactions.

PMID:
42374108
Bibliographic data and abstract were imported from PubMed on 30 Jun 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 5
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement